Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Dermatology

Journal Scan / Research · September 18, 2024

Risk of Acute Upper Respiratory Infections in Patients With Atopic Dermatitis Treated With Dupilumab vs Non-Targeted Immunosuppressants

Journal of the American Academy of Dermatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the American Academy of Dermatology
Dupilumab is associated with reduced risk of acute upper respiratory infections in atopic dermatitis patients compared to non-targeted immunosuppressants: a multi-center cohort study
J Am Acad Dermatol 2024 Aug 30;[EPub Ahead of Print], EZ Ma, A Bao, M Ahmadi, J Zhang, SG Kwatra

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading